<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Koroleva, L.Y.</title>
    <link>http://repub.eur.nl/res/aut/8914/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Clinical utility and cost effectiveness of a personal ultrasound imager for cardiac evaluation during consultation rounds in patients with suspected cardiac disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/8352/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To assess the clinical utility and cost effectiveness of a
      personal ultrasound imager (PUI) during consultation rounds for cardiac
      evaluation of patients with suspected cardiac disease. METHODS: 107
      unselected patients from non-cardiac departments (55% men) were enrolled
      in the study. After the physical examination the consultant cardiologist
      performed an echocardiographic study with a PUI. The final report was
      given instantly to the referring physician. All patients subsequently
      underwent a study with a standard echocardiographic device (SED). For each
      patient the consultant cardiologist noted whether the findings of the PUI
      were adequate for final diagnosis. The total cost when full
      echocardiography was used was compared with the cost when the PUI was
      used. The time interval from request to diagnosis was also compared.
      RESULTS: In 84 (78.5%) patients no further examination with an SED was
      regarded as necessary. Twenty three patients (21.5%) required a further
      detailed examination with the SED because of the need for haemodynamic
      information. There was an excellent agreement for the detection of
      abnormalities between the two devices (96%). The total cost was euro;132
      per patient with the SED and euro;75 per patient with the PUI. According
      to this study, the use of the PUI can lead to a 33.4% reduction of total
      cost. The mean time from request to diagnosis at the authors' institution
      was four days for the SED and instantly for the PUI, for additional
      potential cost savings. CONCLUSIONS: Immediate echocardiographic
      assessment during consultation rounds can lead to significant cost savings
      and can shorten the time to diagnosis.</description>
    </item> <item>
      <title>Left ventricular hypertrophy screening using a hand-held ultrasound device (Article)</title>
      <link>http://repub.eur.nl/res/pub/9975/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>AIMS: To test the diagnostic potential of a hand-held ultrasound device
      for screening for left ventricular hypertrophy in a hypertensive
      population using a standard echocardiographic system as a reference.
      METHODS: One hundred consecutive hypertensive patients were enrolled. An
      experienced investigator performed measurements of the thickness of the
      anterior septum and posterior wall using the parasternal 2D-long axis view
      and the end-diastolic dimension of the left ventricle with both imaging
      devices. Left ventricular hypertrophy was defined as an increase in left
      ventricular mass &gt; or = 134 g x m(-2) for men and &gt; or = 110 g x m(-2) for
      women, when indexed for body surface area and &gt; or = 143 g x m(-1) for men
      and &gt; or = 102 g x m(-1) for women, when indexed for height. RESULTS:
      Sixty-five men and 35 women were studied (age 60 +/- 11 years); mean
      duration of hypertension: 13 +/- 11 years; mean blood pressures: systolic
      150 +/- 20 mmHg and diastolic 89 +/- 11 mmHg. The anterior septum and
      posterior wall were visualized in all patients with both imaging devices.
      The standard echocardiographic system identified left ventricular
      hypertrophy by body surface area in 18 (18%) patients and by height in 26
      (26%) patients. The agreement between the standard echocardiographic
      system and the hand-held device for the assessment of left ventricular
      hypertrophy was 93%, kappa: 0.77 (left ventricular mass/body surface area)
      and 90%, kappa: 0.76 (left ventricular mass/height). CONCLUSIONS: We
      conclude that hand-held devices can be effectively applied for screening
      for left ventricular hypertrophy in hypertensive patients.</description>
    </item>
  </channel>
</rss>